Outcome assessment of a triangular clinic as a harm reduction intervention in Rajaee-Shahr Prison, Iran

Harm Reduction Journal

Volumn 10, Issue 1, 2013, Pages

  Asl, Rahim T ^a   Eshrati, Babak ^b   Dell, Colleen A ^c   Taylor, Kelli ^d   Afshar, Parviz ^e   Kamali, Mohammad ^f   Mirzazadeh, Ali ^g  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e Ministry of Social Welfare   (Iran)

^f IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Health belief model; HIV AIDS; Injection drug use; Triangular clinic

Indexed keywords

ADULT; ARTICLE; BEHAVIOR CHANGE; EDUCATION; EMPLOYMENT; HARM REDUCTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRISON; QUESTIONNAIRE; SEROLOGY; URINALYSIS; VIRUS TRANSMISSION; ATTITUDE TO HEALTH; CONDOM; DISEASE TRANSMISSION; DRUG ABUSE; HEPATITIS B; HEPATITIS C; OUTPATIENT DEPARTMENT; PRISONER; SOCIOECONOMICS; SUBSTANCE ABUSE; TREATMENT OUTCOME; URINE; VIROLOGY;

ADULT; AMBULATORY CARE FACILITIES; CONDOMS; HARM REDUCTION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; IRAN; MALE; NEEDLE SHARING; PRISONERS; PRISONS; RISK-TAKING; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE DETECTION; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 84890913906     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-10-41     Document Type: Article

References (37)

1. Drug Control Bureau Annual report of drug control 2001, Tehran, Drug Control Bureau.
2. Momtazi S, Fallahnejad M, Shoghli A, Musavinasab N, Hajkarim B. Study of high-risk behaviors among injecting drug users in Iran. National Institute of Drug Abuse Conference 2009,
3. National AIDS Committee Secretariat, Ministry of Health and Medical Education Islamic Republic of Iran AIDS Progress Report: On Monitoring of the United Nations General Assembly Special Session on HIV and AIDS 2012, Retrieved from: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/IRIran%20AIDS%20Progress%20Report%202012%20English%20final1_1.pdf, National AIDS Committee Secretariat, Ministry of Health and Medical Education.
4. Ministry of Health and Medical Education HIV/AIDS in Iran (in Persian) 2007, Tehran, Ministry of Health and Medical Education.
5. Mirzazadeh A, Haghdoost A, Doostmohammadi P. Estimating the time trend of adjusted incidence of opioid dependency and multiple factors related to the lag time: backward calculation method. J Kerman Med Univ 2007, 13(3):164-172.
6. Khajehkazemi R, Osooli M, Sajadi L, Karamouzian M, Sedaghat A, Fahimfar N, Safaie A, Mostafavi E, Haghdoost A-A. HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 national surveillance survey. Sex Transm Infect 2013, 1-4. 10.1136/sextrans-2013-051204.
7. Khajehkazemi R, Osooli M, Sajadi L, Karamouzian M, Sedaghat A, Fahimfar N, Safaie A, Mostafavi E, Haghdoost A-A. HIV Prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey. Sex Transm Infect J 2013, 1-4. 10.1136/sextrans-2013-051204.
8. Navadeh S, Mirzazadeh A, Mehdi Gouya M, Farnia M, Alasvand R, Haghdoost A-A. HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey. Sex Transm Infect 2013, 1-4. doi: 10.1136/sextrans-2013-051295.
9. Zamani S, Kihara M, Gouya M, et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr 2006, 42:342-346. 10.1097/01.qai.0000219785.81163.67, 16639351.
10. Zamani S, Farnia M, Torknejad A, Alaei BA, Gholizadeh M, Kasaree F, Ono-Kihara M, Oba K, Kihara M. Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran. J Urban Health 2010, 87(4):603-616. doi:10.1007/s11524-010-9450-8, 10.1007/s11524-010-9450-8, 2900562, 20390391.
11. Tanner I. The Lion Chases Away the Dragon: Iran's drug treatment programs are among the world's most progressive. The Majalla 2013, Retrieved from: http://www.majalla.com/eng/2013/08/article55244942.
12. Farnia M, Ebrahimi B, Shams A, et al. Scaling up methadone maintenance treatment for opioid-dependent prisoners in in Iran. Int J Drug Policy 2010, 21:422-424. 10.1016/j.drugpo.2010.03.008, 20413287.
13. Rosenberg T. An Enlightened Exchange in Iran. The New York Times: The Opinion Pages 2010, Retrieved from: http://opinionator.blogs.nytimes.com/2010/11/29/an-enlightened-exchange-in-iran/.
14. Harrison F. Tackling Iran's growing drugs problem. BBC News: Middle East 2004, Retrieved from: http://news.bbc.co.uk/2/hi/4054703.stm.
15. United Nations Office on Drugs and Crime Triangular Clinic & Rehabilitation Centre 2006, Iran, Retrieved from: http://www.unodc.org/treatment/en/Iran_resource_centre_11.html, United Nations Office on Drugs and Crime.
16. Mehta D. AIDS prevention groups want prison needle programs to protect inmates, public. TV News, The Canadian Press 2013, Retrieved from: http://www.ctvnews.ca/canada/aids-prevention-groups-want-prison-needle-programs-to-protect-inmates-public-1.1502466.
17. Eshrati B, Taghizadeh R, Dell CA, Afshar P, Millson PME, Kamali M, Weekes J. Preventing HIV transmission among Iranian prisoners: initial support for providing education on the benefits of harm reduction practices. Harm Reduct J 2008, 5:21. 10.1186/1477-7517-5-21, 2443130, 18541032.
18. Lenton S, Single E. The definition of harm reduction. Drug Alcohol Rev 1998, 17:213-220. 10.1080/09595239800187011, 16203486.
19. Des Jarlais D. The public health paradigm for AIDS and the drug use: shifting the time frame. Br J Addict 1990, 85:348-349.
20. Shams A, Rabie N, Esmaili A, Baratvand M. The effect of the harm reduction approach in Iran's prisons. IPEDR 2011, 20. Retrieved from: http://www.ipedr.com/vol20/37-ICHSC2011-M10018.pdf.
21. UNODC World Drug Report Vienna: United Nations Office on Drugs and Crime 2005, UNODC.
22. Burrows D. Advocacy and coverage of needle exchange programs: results of a comparative study of harm reduction programs in Brazil, Bangladesh, Belarus, Ukraine, Russian Federation, and China. Cad Saude Publica 2006, 22:871-879. 10.1590/S0102-311X2006000400025, 16612440.
23. UNAIDS Report on the Global AIDS Epidemic Annex 1: HIV and AIDS estimates and data, 2007 and 2001 2008, Geneva, UNAIDS.
24. Razani N, Mohraz M, Kheirandish P, et al. HIV risk behavior among injection drug users in Tehran, Iran. Addiction 2007, 102:1472-1482. 10.1111/j.1360-0443.2007.01914.x, 17645427.
25. Pourahmad M, Javady A, Karimi I, Ataei B, Kassaeian N. Seroprevalence of and risk factors associated with hepatitis B, hepatitis C, and human immunodeficiency virus among prisoners in Iran. Infect Dis Clin Pract 2007, 15:368-372.
26. Fallahzadeh H, Morowatisharifabad M, Ehrampoosh M. HIV/AIDS epidemic features and trends in Iran, 1986-2006. AIDS Behav 2009, 13:297-302. 10.1007/s10461-008-9452-7, 18770025.
27. Zamani S, Vazirian M, Nassirimanesh B, et al. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program. AIDS Behav 2010, 14(4):885-890. 10.1007/s10461-008-9404-2, 18483849.
28. Ghanbarzadeh N, Nadjafi Semnani M. A study of HIV and other sexually transmitted infections among female prisoners in Birjand. J Birjand Univ Med Sci 2006, 13:69-75.
29. Ghannad M, Arab S, Mirzaei M, Moinipur A. Epidemiologic study of human immunodeficiency virus (HIV) infection in the patients referred to health centers in Hamadan Province, Iran. AIDS Res Hum Retrov 2009, 25:277-283.
30. Rahimi-Movaghar A, Razaghi E, Sahimi-Izadian E, Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infec Dis 2010, 14(14):e28-e33.
31. Zamani S, Farnia M, Tavakoli S, et al. A qualitative inquiry into methadone maintenance treatmenmt for opiod-dependent prisoners in Tehran, Iran. Int J Drug Policy 2010, 21(3):167-172. 10.1016/j.drugpo.2009.03.001, 19395250.
32. Rafiey H, Narenjiha H, Shirinbayan P, et al. Needle and syringe sharing among Iranian drug injectors. Harm Reduct J 2009, 6:21. 10.1186/1477-7517-6-21, 2731095, 19643014.
33. Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMenamin J, Green S, Pithie A, Fox R. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?. J Infect 2000, 40:176-183. 10.1053/jinf.2000.0647, 10841096.
34. Vazirian M, Nassirimanesh B, Zamani S, et al. Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study. Harm Reduct J 2005, 2:19. 10.1186/1477-7517-2-19, 1266391, 16212655.
35. Ruefli T, Rogers SJ. How do drug users define their progress in harm reduction programs? Qualitative research to develop user-generated outcomes. Harm Reduct J 2004, 1:8. 10.1186/1477-7517-1-8, 516446, 15333130.
36. Mohammadpour A, Yekta ZP, Nikbakht Nasrabadi AR, Mohraz M. Coming to terms with a diagnosis of HIV in Iran: a phenomenological study. J Assoc Nurses AIDS Care 2009, 20:249-259. 10.1016/j.jana.2009.03.003, 19576542.
37. Jahani MR, Alavian SM, Shirzad H, Kabir A, Hajarizadeh B. Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with " illegal social behavior" Sex Transm Infect 2005, 81:185.